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Isolated complex I deficiency is the most common enzymatic defect of the oxidative phosphorylation (OXPHOS) system, causing a wide range
of clinical phenotypes. We reported before that the rates at which reactive oxygen species (ROS)-sensitive dyes are converted into their fluorescent
oxidation products are markedly increased in cultured skin fibroblasts of patients with nuclear-inherited isolated complex I deficiency. Using
video-imaging microscopy we show here that these cells also display a marked increase in NAD(P)H autofluorescence. Linear regression analysis
revealed a negative correlation with the residual complex I activity and a positive correlation with the oxidation rates of the ROS-sensitive dyes 5-
(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein and hydroethidine for a cohort of 10 patient cell lines. On the other hand, video-imaging
microscopy of cells expressing reduction–oxidation sensitive GFP1 in either the mitochondrial matrix or cytosol showed the absence of any
detectable change in thiol redox state. In agreement with this result, neither the glutathione nor the glutathione disulfide content differed
significantly between patient and healthy fibroblasts. Finally, video-rate confocal microscopy of cells loaded with C11-BODIPY581/591
demonstrated that the extent of lipid peroxidation, which is regarded as a measure of oxidative damage, was not altered in patient fibroblasts. Our
results indicate that fibroblasts of patients with isolated complex I deficiency maintain their thiol redox state despite marked increases in ROS
production.
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NADH:ubiquinone oxidoreductase or complex I (EC 1.6.
5.3.) is the main entry point of metabolic electrons into the
oxidative phosphorylation (OXPHOS) ATP system and its
proper function is essential for the adequate production of ATP.
In accordance with this function, defects in complex I have been
found to be associated with a wide range of human disorders
including early onset, fatal clinical phenotypes such as Leigh
and Leigh-like syndrome, encephalomyopathy and cardiomyo-
pathy [1]. In mammals, the complex consists of 38 nuclear-
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having a molecular weight close to 1 MDa [2–4]. As far as the
nuclear genome is concerned, disease-causing mutations have
been identified in nine complex I subunits [5–8] and the
complex I assembly factor B17.2L [9].
At the cellular level, these mutations were shown to
decrease the amount of catalytically active complex [10]. Live
cell studies revealed that the consequent decrease in NADH-
oxidizing capacity was associated with altered mitochondrial
morphology [11], disturbed Ca2+ and ATP handling [12,13]
and increased rates of ROS production [14–16].
In healthy cells, the large majority of ROS are generated as
a consequence of oxidative phosphorylation [17,18].
OXPHOS-derived ROS levels, carefully balanced by ROS
scavenging systems, have been suggested to play an important
signaling role in gearing mitochondrial and cellular physiol-
ogy for one another [19,20]. Most probably, ROS act through
promoting the reversible S-glutathionylation of regulatory
proteins by glutathione S-transferases [21]. Evidence has been
provided that OXPHOS-derived ROS predominantly originate
from reduced flavin in complex I [22]. The fraction of
reduced flavin was found to depend on the ratio and
concentrations of NADH and NAD+, thus explaining previous
findings that NADH to NAD+ ratio and ROS production are
closely correlated [23–27]. Increased ROS production, as
observed in cultured cells of complex I deficient patients (see
above), may result in a condition of oxidative stress that, if
persistent, may lead to cellular injury and, eventually, death
[28,29].
The cell's redox environment is crucial in integrating
multiple metabolic, signaling and transcriptional processes
[30]. Because of the high intracellular glutathione concentra-
tion (1–11 mM), the glutathione disulfide (GSSG)–glutathione
(GSH) redox couple is widely believed to be the major
determinant of the cell's redox environment [31,32]. GSH
can react nonenzymatically with ROS or function as a
substrate for glutathione peroxidases and glutathione S-trans-
ferases [32,33]. Glutathione peroxidases catalyze the conver-
sion of H2O2 to water, whereas glutathione S-transferases
reversibly S-glutathionylate proteins to buffer excess ROS
production [21]. Moreover, these transferases conjugate GSH
with toxic products from lipid peroxidation such as 4-
hydroxynonenal [34]. GSH is synthesized in the cytosol,
from where it is imported into the mitochondrial matrix [35]. A
number of studies have implicated the mitochondrial GSH
pool in the loss of cell viability evoked by cellular GSH
depletion [36,37]. Recent work demonstrated an increased
sensitivity of mitochondrial GSH-depleted cells to peroxyni-
trite-induced damage [38]. In other studies, induction of
mitochondrial oxidative stress was shown to decrease the
mitochondrial GSH pool and to increase membrane lipid
peroxidation [34].
Here, we provide evidence that the subcellular redox
environment is not detectably altered in cultured skin fibroblasts
of patients with nuclear-inherited isolated complex I deficiency.
In agreement with this result, no significant changes in lipid
peroxidation were observed.2. Materials and methods
2.1. Patient skin fibroblasts
Fibroblasts were derived from skin biopsies of ten patients in the age range
of 0–5 years (P1–P10) in whom an isolated NADH:ubiquinone oxido-
reductase deficiency was confirmed in both muscle tissue and cultured
fibroblasts and ten healthy control subjects, five adults (CT1–CT5) and five
age-matched children (CT6–CT10), following informed consent and according
to relevant institutional review boards (Table 1). Genetic characterization
revealed disease-causing mutations in either the NDUFV1 (P1–P2), NDUFS1
(P3), NDUFS2 (P4–P5), NDUFS4 (P6–P8), NDUFS7 (P9) or NDUFS8 (P10)
gene of complex I [7]. None of the patients harbored mitochondrial DNA
mutations previously associated with CI deficiency. Measurement of complex
I activity was performed in a mitochondria-enriched fraction obtained from
cultured skin fibroblasts as described previously [39]. The activity of the
complex was normalized against that of complex IV (cytochrome c oxidase),
which was measured in the same fraction, and expressed as percentage of
lowest control (110 mU/U cytochrome c oxidase; [39]). Fibroblasts were
cultured in medium 199 with Earle's salt supplemented with 10% (v/v) fetal
calf serum, 100 IU/ml penicillin and 100 IU/ml streptomycin in a humidified
atmosphere of 95% air and 5% CO2 at 37 °C. Initial passage numbers are
given in Verkaart et al. [15] and measurements were performed within 5
passages. Cell cycle analysis revealed no differences between the various cell
lines [11].
2.2. Quantification of intracellular NAD(P)H autofluorescence
For measurement of intracellular NAD(P)H autofluorescence, fibroblasts
were seeded on glass coverslips (Ø24 mm) and cultured to ∼70% confluence.
Immediately prior to measurement, cells were transferred to a HEPES–Tris
medium (132 mM NaCl, 4.2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 5.5 mM D-
glucose and 10 mM HEPES, pH 7.4) and coverslips were mounted in an
incubation chamber placed on the stage of an inverted microscope (Axiovert
200 M, Carl Zeiss, Jena, Germany) equipped with a Zeiss 40×/1.3 NA Plan
NeoFluar objective. The cells were excited at 360 nm using a monochromator
(Polychrome IV, TILL Photonics, Gräfelfing, Germany). Fluorescence emission
light was directed by a 415DCLP dichroic mirror (Omega Optical Inc.,
Brattleboro, VT, USA) through a 510WB40 emission filter (Omega Optical Inc.)
onto a CoolSNAP HQ monochrome CCD-camera (Roper Scientific, Vianen,
The Netherlands). The imaging setup was controlled by Metafluor 6.0 software
(Universal Imaging Corporation, Downingtown, PA, USA). Routinely, 10 fields
of view were analyzed per coverslip using an image capturing time of 100 ms.
The mean fluorescence intensity was determined in an intracellular region of
interest and, for purpose of background correction, an extracellular region of
identical size. Quantitative image analysis was performed with Metamorph 6.0
(Universal Imaging Corporation). In each experiment, the average value
obtained with healthy fibroblasts was set at 100%, to which all other values were
related.
2.3. Quantification of hydroethidine and CM-H2DCF oxidation
Quantitative determination of fluorescent oxidation products of hydro-
ethidine (HEt) and (5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein
(CM-H2DCF) was performed as described previously [15,40,41]. Briefly,
fibroblasts, grown to ∼70% confluence on glass coverslips, were incubated
in HEPES–Tris medium containing either 10 μM HEt or 1 μM CM-
H2DCFDA for 10 min at 37 °C. After thorough washing to remove non-
oxidized HEt or non-hydrolyzed CM-H2DCFDA, coverslips were mounted
in an incubation chamber placed on the stage of either the video-imaging
microscope or a confocal microscope (Noran Instruments, Middleton, WI,
USA). Initial measurements revealed that the formation of fluorescent
oxidation products occurred linearly with time during both the incubation
period in the presence of HEt (data not shown) and the imaging period in
the presence of CM-H2DCF [41], indicating a zero-order reaction
mechanism. This means that in both cases the rate of fluorescence increase
is a measure of the level of the oxidant that oxidizes the dye. HEt is thought
to be primarily oxidized by superoxide, whereas superoxide-derived ROS are
Table 1
NADH(P)H autofluorescence, oxidation of ROS-sensitive dyes and extent of lipid peroxidation














Average CT 106±2.4 98.3±6.69 100±0.66 108±8.33 115±10
CT1 (#5120) None 113 100±2 (n=143) 100±1 (n=526) 100±2 (n=412) 100±3 (n=99)
CT2 (#5119) None 105 86±2 (n=101) 102±2 (n=89) 100±11 (n=48) 135±5 (n=112)
CT3 (#5118) None 103 109±3 (n=94) 98±3 (n=126) 125±13 (n=61) 110±4 (n=108)
CT4 (#4996) None n.d. n.d. 100±3 (n=95) n.d. n.d.
CT5 (#223V) None 103 n.d. 99±3 (n=94) n.d. n.d.
Average P 49±6.3 142±7.23 181±14.0 223±20.8 112±4
P1 (#5171) NDUFV1-R59X/T423M 73 130±9 (n=18) 186±6 (n=84) 242±19 (n=78) 92±3 (n=73)
P2 (#5866) NDUFV1-R59X/T423M 64 142±4 (n=93) 110±3 (n=61) 135±12 (n=49) 123±3 (n=108)
P3 (#6173) NDUFS1-D618N/R577X 31 142±5 (n=60) 176±4 (n=83) 171±13 (n=87) 109±3 (n=74)
P4 (#5170) NDUFS2-R228Q 39 140±7 (n=61) 205±8 (n=66) 169±7 (n=124) 115±4 (n=101)
P5 (#5067) NDUFS2-P229Q 36 191±6 (n=102) 264±9 (n=100) 351±41 (n=28) 115±5 (n=64)
P6 (#5260) NDUFS4-R106X 36 132±4 (n=114) 174±8 (n=64) 187±12 (n=160) 127±4 (n=64)
P7 (#5737) NDUFS4-VPEEHI67/VEKSIstop 53 127±6 (n=70) 131±4 (n=92) 202±12 (n=98) 115±4 (n=81)
P8 (#4608) NDUFS4-K158fs 75 130±4 (n=62) 195±6 (n=106) 289±46 (n=29) 123±5 (n=76)
P9 (#5175) NDUFS7-V122M 68 112±7 (n=40) 151±5 (n=94) 212±15 (n=76) 87±3 (n=99)
P10 (#6603) NDUFS8-R94C 18 170±6 (n=62) 222±7 (n=147) 275±20 (n=117) 111±3 (n=90)
Statistics: values in bold are below the lowest control value (CI activity) or significantly different (pb0.05) from highest control (NAD(P)H autofluorescence, rate of
HEt oxidation, rate of CM-H2DCF oxidation). Values between brackets represent the number of individual cells analyzed on at least 2 days.
a Numbers indicate the designation of the cell lines within the Nijmegen Centre for Mitochondrial Disorders (NCMD). CT and P indicate control and patient cell
lines, respectively.
b Mutations are given at the protein level.
c Enzymatic activities were measured in mitochondria-enriched fractions and expressed as % of the lowest control value (110 mU/U cytochrome c oxidase).
d Determined previously and expressed as % of CT1 [15,16].
e Expressed as % of CT1.
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average value obtained with healthy fibroblasts was set at 100%, to which
all other values were related.
2.4. Quantification of cytosolic and mitochondrial thiol redox state
cDNA's encoding roGFP1 and mitochondria-targeted roGFP1 [42,43] were
digested from a pEGFP-N1 vector backbone using EcoRI/XbaI and NdeI/XbaI,
respectively. For expression in mammalian cells, inserts were ligated into a
modified pFastbacdual transfer vector [12]. RoGFP1 contains surface-exposed
cysteine residues that form disulfide bonds upon oxidation. The fluorescence
emission ratio after excitation at 400 nm (oxidized state) and 480 nm (reduced
state) is a measure of the ambient redox potential [42,43]. The ratiometric nature
of the probe minimizes errors associated with changes in roGFP1 expression,
photobleaching, and variations in cell thickness [43]. Moreover, roGFP1
fluorescence is pH-independent, which allows comparison of roGFP1 signals
between the cytosolic and the more alkaline mitochondrial matrix [17]. For
roGFP1 experiments, human skin fibroblasts, seeded on glass coverslips
(Ø 24 mm), were cultured for 24 h, infected with the appropriate baculovirus and
cultured for another 48 h. Immediately prior to fluorescence measurement,
fibroblasts were transferred to HEPES–Tris medium and coverslips were
mounted in an incubation chamber placed on the stage of the video-imaging
microscope. RoGFP1 was alternately excited at 400 and 480 nm using the
monochromator and fluorescence emission light was directed by a 525DRLP
dichroic mirror (Omega Optical Inc.) through a 535DF25 emission filter (Omega
Optical Inc.) onto the CCD-camera. Image capturing time was 300 ms and a pair
of images was taken every 5 s. For each wavelength, the mean fluorescence
intensity was monitored in an intracellular region and, for purpose of
background correction, an extracellular region of identical size. After
equilibration for 3 min, cells were successively treated with 1 mM hydrogen
peroxide (100% oxidation) and 10 mM dithiothreitol (100% reduction). After
background correction, the fluorescence emission ratio after excitation at
400 nm (oxidized state) and 480 nm (reduced state) was calculated and the
percentage oxidation was determined.2.5. Determination of GSSG and GSH content in whole-cell
homogenates
Preparation of cell extracts and measurement of cellular GSSG and GSH
content were performed using HPLC as described previously [44]. Values were
expressed as nmol/mg protein.
2.6. Quantification of the extent of lipid peroxidation
Measurement of the extent of lipid peroxidation was performed as described
before [40]. Briefly, fibroblasts, grown to ∼70% confluence on glass coverslips,
were incubated in HEPES–Tris medium containing 4 μM C11-BODIPY581/591
for 30 min at 37 °C. Upon oxidation, the red emitting form of the dye (595 nm) is
converted into a green emitting form (520 nm). After thorough washing, cells
were excited at 488 nm and images were collected using the video-rate confocal
microscope. Green and red fluorescence emission signals were separated using a
560 DM dichroic mirror and appropriate band-pass filters (535D20 and 580LP;
Chroma Technology Corp.). In each experiment, the average of the green to red
fluorescence emission ratios obtained with healthy fibroblasts was set at 100%,
to which all other values were related.
2.7. Data analysis and statistics
Numerical results were visualized using Origin Pro 7.5 (Originlabs,
Northampton, MA, USA) and are expressed as means±S.E. During linear
regression analysis, we used Pearson's correlation coefficient R (or product
moment correlation coefficient) as an estimate of the population correlation
coefficient. R values of −1 and +1 indicate a perfect linear correlation between
the two variables. For RN0 this correlation is positive, whereas for Rb0 it is
negative. During non-linear regression analysis, we used the coefficient of
determination (R2) to express the proportion of the total variation that is
explained by the regression. An R2 value of +1 indicates that the total variation
in the y-variable can be explained in terms of the regression curve. Statistical
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population Student's t-test (Bonferroni corrected). p values b0.05 were con-
sidered significant.
2.8. Chemicals
Culture materials and fluorescent probes were obtained from Invitrogen
(Breda, The Netherlands). All other reagents were from Sigma (Zwijndrecht, the
Netherlands).
3. Results
3.1. Effect of acute rotenone treatment on NAD(P)H
autofluorescence in healthy fibroblasts
To investigate whether a decrease in complex I activity can
alter the NADH level, we performed video-imaging micro-
scopy of pyridine nucleotide autofluorescence. Because
NADPH and NADH have similar spectral properties, an
increase in fluorescence intensity reflects de facto a net shift in
the pyridine nucleotide pool towards the more reduced state
[17]. In fibroblasts of a healthy control subject (Table 1; CT1),
NAD(P)H autofluorescence mainly originated from elongated
tubular structures present in the cytosolic compartment. In
previous studies, similar structures were identified as mito-
chondrial filaments [11,15,40,45]. To have an estimate of the
NAD(P)H level in the mitochondrial matrix, we routinely
determined its autofluorescence from a circular region of
interest harboring a high density of mitochondrial filaments.
For background correction, an extracellular region of similarFig. 1. Acute rotenone treatment increases NAD(P)H autofluorescence and HEt oxid
FCCP (1 μM) or rotenone (1 μM) for 2 min and subsequently monitored for NAD(
fluorescence pixel intensity was calculated for a mitochondria-rich region as a measur
with vehicle-treated CT1 cells was set at 100%, to which all values were related. N
⁎Significantly different from vehicle-treated control (pb0.05). (B) Dose–response
(open symbols) and accumulation of hydroethidine (HEt) oxidation products (clos
indicated concentration of rotenone for 10 min, thoroughly washed to remove non-oxi
fluorescence pixel intensity was calculated for a mitochondria-rich region as a meas
measured on at least three days and expressed relative to the average fluorescence
(C) Positive linear correlation between NAD(P)H autofluorescence and HEt oxidatsize was used. Average NAD(P)H autofluorescence remained
constant for at least 2 min, but was greatly reduced to 59±3%
of baseline upon short-term treatment with the mitochondrial
uncoupler p-trifluoromethoxy carbonyl cyanide phenyl hydra-
zone (FCCP; 1 μM; 2 min) (Fig. 1A; right bar). In sharp
contrast, acute treatment with rotenone (1 μM; 2 min)
markedly increased the autofluorescence signal to 149±9%
of baseline (Fig. 1A; middle bar). The effect of rotenone was
dose-dependent with half-maximal and maximal inhibitor
concentrations of 100 nM and 1 μM, respectively (Fig. 1B,
open symbols; R2 =0.93).
3.2. Relationship between NAD(P)H autofluorescence and HEt
oxidation in healthy fibroblasts acutely treated with rotenone
Next, we evaluated the effect of acute inhibition of complex I
on the oxidation rate of hydroethidine (HEt) as a putative
measure of the intracellular superoxide level. Fibroblasts were
incubated with 10 μM HEt and the indicated concentration of
rotenone for 10 min, thoroughly washed to remove non-
oxidized HEt, and subsequently imaged for quantification of the
fluorescent HEt oxidation products formed during the 10-min
incubation period with HEt. Importantly, we showed before that
the average fluorescence intensity remained stable for at least
10 min, indicating that non-oxidized HEt was effectively
removed during the washing step and that its oxidation products
did not translocate during the ensuing recording period [15,40].
In addition, we demonstrated that these products accumulated
in elongated tubular structures similar to those observed ination rate in healthy fibroblasts. (A) CT1 cells (Table 1) were treated with either
P)H autofluorescence by video-imaging microscopy. For each cell, the average
e of the local NAD(P)H level. On each measuring day, the average value obtained
umerals represent the number of individual cells analysed on at least 3 days.
curve for the effect of acute rotenone treatment on NAD(P)H autofluorescence
ed symbols). In the latter case, cells were incubated with 10 μM HEt and the
dized dye and subsequently subjected to video-imaging microscopy. The average
ure of the local superoxide level. The effect of each rotenone concentration was
intensity obtained with vehicle-treated CT1 cells measured on the same day.
ion rate in rotenone-treated CT1 cells (data are from panel B).
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of rotenone dose-dependently increased the rate of HEt
oxidation in a mitochondria-rich region of interest (Fig. 1B,
closed symbols; R2 =0.95). Half-maximal and maximal inhi-
bitor concentrations were 10 nM and 100 nM, respectively.
Linear regression analysis revealed a positive correlation
between HEt oxidation rate and NAD(P)H autofluorescence
for the whole range of rotenone concentrations (Fig. 1C;
R=0.84, p=0.002).
3.3. Relationship between NAD(P)H autofluorescence and
residual complex I activity in patient fibroblasts
Fibroblasts of complex I deficient patients displayed a
similar density of mitochondrial filaments in the perinuclear
region as healthy fibroblasts. Measurement of the average
NAD(P)H autofluorescence in this mitochondria-rich region
showed a significant increase in all but one of the patient cell
lines (P9; Table 1). Linear regression analysis revealed a
negative correlation between NAD(P)H autofluorescence and
residual complex I activity for the whole cohort of patient cell
lines (Fig. 2A; R=−0.87; pb0.001).
3.4. Relationship between NAD(P)H autofluorescence and HEt
and CM-H2DCF oxidation in patient fibroblasts
All but one of the patient cell lines (P2; Table 1) were
reported before to display significantly increased rates of HEt
and CM-H2DCF oxidation as putative measures of the
intracellular levels of superoxide [15,16] and derived ROS
[16,41], respectively. Similar as in healthy fibroblasts acutely
treated with rotenone, NAD(P)H autofluorescence and HEt
oxidation rate were positively correlated for the whole cohort
of patient cell lines (Fig. 2B; R=0.81, pb0.001). Likewise,Fig. 2. Correlation between NAD(P)H autofluorescence, residual complex I activity
linear correlation between residual complex I activity and NAD(P)H autofluorescen
oxidation rate. (C) Positive linear correlation between NAD(P)H autofluorescence alinear regression analysis revealed a positive correlation
between NAD(P)H autofluorescence and CM-H2DCF oxida-
tion rate (Fig. 2C; R=0.86; pb0.001).
3.5. Total cellular glutathione content and GSSG to GSH ratio
in patient fibroblasts
The results obtained thus far are in agreement with the idea
that the large majority of patient cell lines exhibit a marked
increase in NADH level and superoxide and derived ROS
levels. This leaves the question of whether and, if so, how the
cellular redox environment is altered under these conditions.
Evidence has been provided that the ratio between GSH and its
oxidized form (GSSG) serves as a major determinant of the
cell's redox environment [31]. To establish whether complex I
deficiency affects the redox state of this couple, we determined
the GSSG and GSH content in whole-cell homogenates of 10
healthy and 10 patient fibroblast cell lines using high
performance liquid chromatography. Table 2 shows that on
average neither the GSSG nor GSH content differed signifi-
cantly between fibroblasts of healthy subjects and complex I
deficient patients (p values of 0.55 and 0.36, respectively).
Similarly, the ratio of GSSG to GSH did not differ between
healthy and patient fibroblasts (p=0.13).
3.6. Determination of the subcellular thiol redox state using
organelle-targeted roGFP1
To investigate the possibility that the subcellular redox
environment is altered in human complex I deficiency, healthy
and patient fibroblasts were transduced with recombinant
baculoviruses containing the DNA for roGFP1, a redox-sensitive
variant of the green fluorescent protein. RoGFP1 was either
expressed in the cytosol (cyt-roGFP1) or targeted exclusively toand rates of HEt and CM-H2DCF oxidation in patient fibroblasts. (A) Negative
ce. (B) Positive linear correlation between NAD(P)H autofluorescence and HEt
nd rate of CM-H2DCF oxidation (see Results for details).
Table 2
Cellular thiol redox status
Cell line a mit-roGFP1 b cyt-roGFP1b GSH+GSSGc GSSGc (oxidized) GSHc (reduced) GSSG/GSH
Average CT 44.6±2.16 17.6±1.25 26.9±1.8 0.793±0.033 26.1±1.8 0.031±0.0020
CT1 (#5120) 38±2 (n=42) 15±1 (n=23) 25.1 0.911 24.2 0.038
CT2 (#5119) 48±4 (n=24) 20±3 (n=14) 25.4 0.722 24.7 0.029
CT3 (#5118) 44±4 (n=22) 14±2 (n=11) 28.0 0.831 27.1 0.031
CT4 (#4996) 39±4 (n=21) 20±2 (n=8) 25.7 0.805 24.9 0.032
CT5 (#223V) 45±4 (n=18) 18±4 (n=11) 25.6 0.748 24.9 0.030
CT6 (#MW21) 49±4 (n=23) 19±3 (n=18) 31.2 0.946 30.3 0.031
CT7 (#MW25) 59±4 (n=15) 25±1 (n=12) 26.9 0.749 26.2 0.029
CT8 (#MW28) 40±5 (n=11) 19±3 (n=6) 36.3 0.861 35.5 0.024
CT9 (#MW33) 48±7 (n=11) 15±4 (n=3) 30.8 0.782 30.0 0.026
CT10 (#MW35) 36±6 (n=9) 11±1 (n=10) 14.1 0.577 13.5 0.043
Average P 43.3±2.05 21.5±1.40 24.8±1.4 0.830±0.050 24±1.4 0.035±0.0010
P1 (#5171) 40±3 (n=20) 19±3 (n=23) 29.2 1.014 28.2 0.036
P2 (#5866) 44±4 (n=23) 15±1 (n=13) 21.6 0.742 20.9 0.036
P3 (#6173) 49±5 (n=14) 20±2 (n=12) 23.0 0.904 22.1 0.041
P4 (#5170) 44±5 (n=19) 18±2 (n=14) 27.9 0.783 27.1 0.029
P5 (#5067) 36±3 (n=21) 27±2 (n=21) 31.7 0.986 30.7 0.032
P6 (#5260) 52±4 (n=22) 26±2 (n=13) 19.4 0.587 18.8 0.031
P7 (#5737) 54±3 (n=44) 26±2 (n=31) 19.7 0.732 19.0 0.039
P8 (#4608) 40±3 (n=28) 24±3 (n=15) 24.3 0.902 23.4 0.039
P9 (#5175) 37±3 (n=20) 16±1 (n=22) 21.9 0.630 21.3 0.030
P10 (#6603) 37±3 (n=34) 24±2 (n=29) 29.5 1.017 28.5 0.036
a Numbers indicate the designation of the cell lines within the Nijmegen Centre for Mitochondrial Disorders (NCMD). CT and P indicate control and patient cell
lines, respectively.
b Data reflects the % of oxidized roGFP1 in the mitochondrion (mit-roGFP1) and cytosol (cyt-roGFP1); values between brackets represent the number of individual
cells analyzed on at least 4 days.
c Expressed as nmol/mg protein, determined in two independent experiments.
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readily expressed and their fluorescence was determined in
circular regions marked ‘m’ (Fig. 3A) and ‘c’ (Fig. 3B),
respectively. For background correction, an extracellular region
of similar size (marked ‘b’) was used. Fig. 1C depicts the ratio of
the fluorescence emission intensities after excitation at 400 and
480 nm as a function of time. To establish the extent of roGFP1
oxidation, ratio signals were calibrated by successive treatment
with 1 mM hydrogen peroxide (H2O2) and 10 mM dithiothreitol
(DTT) to fully oxidize (100% oxidation) and reduce (0%
oxidation) the probe, respectively [43]. H2O2 gradually increased
the fluorescence emission ratio to a maximum reached within
350 s, whereas subsequent addition of DTT rapidly reduced this
ratio to below pre-H2O2 levels. Higher concentrations of H2O2
and DTTcaused no further change in fluorescence emission ratio,
indicating that the probe was maximally oxidized and reduced,
respectively. Fig. 3C shows that for healthy fibroblasts (Table 1;
CT1), the extent of roGFP1 oxidation was higher in the
mitochondrial matrix than in the cytosol.
3.7. Effect of GSH depletion on the subcellular thiol redox state
in healthy fibroblasts
To assess the relevance of the GSSG/GSH couple in
preserving the subcellular redox environment, healthy fibro-
blasts were cultured in the presence of 12.5 μM L-buthionine-
(S,R)-sulphoximine (BSO) for 72 h. BSO is a potent inhibitor of
γ-glutamylcysteine synthetase, the rate limiting enzyme in the
synthesis of GSH [46], and it has been demonstrated that
chronic treatment with this drug effectively depletes GSH[47,48]. BSO dramatically increased the extent of roGFP1
oxidation in both mitochondrial matrix (Fig. 3D) and cytosolic
compartment (Fig. 3E). Moreover, this inhibitor caused a
marked decrease in the rate of HEt oxidation (Fig. 3F), whereas,
in sharp contrast, it substantially increased the rate of CM-
H2DCF oxidation (Fig. 3G). Moreover, it slightly increased
NAD(P)H autofluorescence (Fig. 3H).
3.8. Effect of chronic rotenone treatment on the subcellular
thiol redox state in healthy fibroblasts
We previously showed that chronic rotenone treatment
dose-dependently reduced the activity of complex I in healthy
fibroblasts [40]. To determine whether complex I deficiency
could, in principle, alter the subcellular redox environment,
healthy fibroblasts (Table 1; CT1) were treated with 100 nM
rotenone for 72 h. This treatment slightly but significantly
(pb0.05) increased the extent of mit-roGFP1 and cyt-roGFP1
oxidation (Fig. 3D and E, respectively). Experiments
performed in parallel confirmed previous work [15] showing
that chronic rotenone treatment increased the rate of HEt
oxidation (Fig. 3F). Surprisingly, this treatment did not alter
the rate of CM-H2DCF oxidation (Fig. 3G), whereas it
markedly increased NAD(P)H autofluorescence (Fig. 3H).
3.9. Measurement of the subcellular thiol redox state in patient
fibroblasts
To establish whether complex I deficiency is associated with
a change in subcellular redox environment, fibroblasts of 10
Fig. 3. Quantitative measurement of subcellular thiol redox state with roGFP1. (A) Fluorescence image (400 nm excitation) of a healthy fibroblast (Table 1; CT1)
transiently expressing the mitochondria-targeted variant of roGFP1 (mito-roGFP1). (B) The same following transient expression of the cytosolic variant of roGFP1
(cyt-roGFP1). Circles represent regions of interest used for quantitative measurement of thiol redox state in the mitochondrial matrix (m), the cytosolic compartment
(c) and an extrecellular region used for background correction (b). (C) Quantification of the subcellular thiol redox state using 1 mM H2O2 (maximal oxidation) and
10 mMDTT (maximal reduction). After background correction, the 400/480 nm fluorescence excitation intensity was calculated. Note that roGFP1 is more oxidized in
the mitochondrial matrix. (D, E) CT1 fibroblasts, transiently expressing organelle-targeted roGFP, were treated with either rotenone (100 nM) or BSO (12.5 μM) for
72 h and used for analysis of the thiol redox state in the (D) mitochondrial matrix and (E) cytosolic compartment as described above. (F–H) CT1 cells, chronically
treated with either rotenone or BSO, were subjected to video-imaging microscopy for quantification of the rates of (F) HEt oxidation and (G) CM-H2DCF oxidation
and (H) NAD(P)H autofluorescence as described in the legend to Fig. 1. On each day, the average value obtained with vehicle-treated CT1 cells was set at 100%, to
which all values were related. Numerals indicate the number of cells analyzed on at least 3 days. ⁎Significantly different from vehicle-treated control (pb0.05).
1047S. Verkaart et al. / Biochimica et Biophysica Acta 1772 (2007) 1041–1051healthy subjects and 10 patients were transduced with mit-
roGFP1 and cyt-roGFP1 and analyzed as described above. In all
cases, mit-roGFP1 was significantly more oxidized than cyt-
roGFP1 (Table 2). Unexpectedly, however, no significant
differences in mitochondrial and/or cytosolic roGFP1 oxidation
were observed between healthy and complex I deficient cell
lines.
3.10. Measurement of lipid peroxidation in patient fibroblasts
We previously showed that chronic rotenone treatment
(100 nM, 72 h) significantly increased the extent of lipid
peroxidation in healthy fibroblasts and that this effect of the
inhibitor was abolished by the mitochondria-targeted antiox-
idant mitoquinone [40]. Here, we used the same measuringprotocol but could not detect any difference in the extent of lipid
peroxidation between patient cell lines and cell lines of healthy
subjects (Table 1).
4. Discussion
In this study, we measured the thiol redox state as an
important determinant of the redox environment in both the
cytosol and mitochondrial matrix of cultured skin fibroblasts of
10 healthy control subjects and 10 patients with nuclear-
inherited isolated complex I deficiency. In addition to previously
reported increases in oxidation rates of hydroethidine (HEt) and
CM-H2DCF as putative measures of intracellular superoxide
[15,16] and derived ROS [16,41] levels, respectively, we here
show that NAD(P)H autofluorescence is increased in a mito-
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mitochondrial NADH level. Strikingly, however, neither the
thiol redox state nor the extent of lipid peroxidation differed
significantly between the healthy and patient cell lines.
4.1. HEt and CM-H2DCF are primarily oxidized by different
ROS
Studies with isolated mitochondria have indicated that
OXPHOS-derived superoxide is predominantly released into
the mitochondrial matrix, where it is rapidly converted into
hydrogen peroxide (H2O2) [49]. The mitochondrial matrix is
devoid of catalase and uses glutathione peroxidase (GPX) to
fully reduce H2O2 into water. Reducing equivalents are obtained
from glutathione (GSH), which is oxidized to glutathione
disulfide (GSSG) [50]. We showed before that exogenous H2O2
readily increased the rate of CM-H2DCF oxidation, without
altering the rate of HEt oxidation [40]. Here, we show that
chronic BSO treatment increased the rate of CM-H2DCF
oxidation, whereas, at the same time, it decreased the rate of
HEt oxidation, indicating that the ROS that oxidize CM-H2DCF
do not oxidize HEt. On the other hand, chronic rotenone
treatment increased the rate of HEt oxidation, whereas, at the
same time, it did not alter the rate of CM-DCF formation. These
findings are compatible with the idea that HEt is mainly
oxidized by superoxide, whereas CM-H2DCF is predominantly
oxidized by superoxide-derived ROS. Because the formation of
fluorescent oxidation products occurred linearly with time, the
rate of fluorescence increase, then, is a measure of the
superoxide and derived ROS level, respectively.
4.2. Cellular NAD(P)H levels are increased in
nuclear-inherited complex I deficiency
The present study reveals that steady-state NAD(P)H levels
are increased in virtually all patient cell lines with biochemi-
cally diagnosed complex I deficiency. A negative linear
correlation was found between NAD(P)H autofluorescence
and complex I-specific NADH oxidizing capacity, suggesting
that the observed increase in NAD(P)H autofluorescence
reflects primarily an increase in NADH level. This conclusion
was substantiated by the finding that healthy fibroblasts
displayed a dose-dependent increase in NAD(P)H autofluor-
escence following acute inhibition of complex I by rotenone.
The present study furthermore reveals a positive linear
correlation between NAD(P)H and superoxide levels. The
same correlation was observed for healthy fibroblasts acutely
treated with rotenone. These results are in agreement with
earlier findings [23–27] and support the idea that complex I
deficiency increases the fraction of reduced flavin in complex I
and, thus, OXPHOS-derived superoxide production [22]. Here
it should be noted, however, that the situation might be
different in other model systems. For instance, using isolated
guinea pig hearts it was found that the complex I inhibitor
amobarbital attenuated the increase in HEt oxidation but not
the increase in NAD(P)H autofluorescence during 30 min of
ischemia [51].4.3. Cellular redox environment is not detectably altered in
nuclear-inherited complex I deficiency
It has been suggested that the redox state of roGFP1 is
determined by the reducing capacity of the most important
redox buffer within the cell [42]. Here, we show that inhibition
of GSH synthesis by L-buthionine-(S,R)-sulphoximine (BSO)
resulted in virtually complete oxidation of both mit- and cyt-
roGFP1. This result indicates that the GSSG/GSH redox couple
is the most important determinant of the subcellular redox
environment in human skin fibroblasts. ROS despite a marked
increase in the intracellular levels of superoxide and derived
ROS, the total cellular GSH content and the GSSG to GSH ratio
were not detectably altered in a large cohort of patient cell lines.
In agreement with this result, measurements with roGFP1
revealed no significant differences in thiol redox state between
patient and healthy fibroblasts. A similar lack of effect of
increased ROS levels on the oxidation state of roGFP1 was
observed in EGF-treated NR6 cells [42]. Our results disagree
with a recent study showing a decrease in total cellular
glutathione content in patient fibroblasts with a mutation in
the NDUFS1 gene [14]. However, the latter study included only
one healthy control cell line and we show here that the total
cellular glutathione content varied over the same range in both
the patient and healthy control group. In agreement with our
results, the total cellular glutathione content was previously
found to be unaltered in patient fibroblasts with a mutation in
the NDUFS4 gene [14].
Taken together, our findings show that patient fibroblasts are
able to maintain the thiol redox state and, consequently, the
cellular redox environment, despite marked increases in super-
oxide and derived ROS levels. Because GSSG, produced by the
action of GPX, is reconverted to GSH by enzymes that use
NADPH as electron donor [52] and NAD(P)H levels are
increased in patient fibroblasts, it may be speculated that the
absence of any detectable change in cellular redox environment
is due to the increased action of these enzymes. As far as the
mitochondrial matrix is concerned, evidence has been provided
that NADP+-dependent isocitrate dehydrogenase is a major
producer of mitochondrial NADPH [53], whereas, in addition,
NADH can be converted into NADPH by the action of
mitochondrial transhydrogenase [54].
In both healthy and patient fibroblasts mit-roGFP1 (values of
45% and 43%, respectively) was significantly more oxidized
than cyt-roGFP1 (values of 18% and 22%, respectively).
Similar results were obtained with HeLa cells (values of 33%
and 18%, respectively; [42,43]). The finding that the redox
environment is more oxidized in the mitochondrial matrix is in
accordance with the observation that the large majority of
cellular ROS is produced as a consequence of oxidative
phosphorylation [17,18,49,55].
BSO slightly increased the NAD(P)H level, suggesting that
the mitochondrial redox environment is a determinant of
OXPHOS function. In agreement with this conclusion, oxidation
of the mitochondrial GSH pool was found to reduce the activity
of complex I [56]. Furthermore, BSO decreased the superoxide
level, whereas, at the same time, it markedly increased the
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scavenging superoxide-derived ROS. The latter two findings are
in agreement with the recent observation that BSO increases the
expression of superoxide dismutases [57,58].
Our results with BSO and rotenone show that the absence of
any detectable alteration in subcellular thiol redox state is not
due to a lack of sensitivity of roGFP1 because BSO almost
completely oxidized this sensor, whereas rotenone, at a
concentration shown before to inhibit the activity of complex
I by ∼80% [40], only slightly increased the amount of oxidized
roGFP1. The results obtained with this inhibitor substantiate our
conclusion that complex I deficiency only slightly, if at all,
oxidizes the subcellular redox environment in human skin
fibroblasts. As speculated above, this finding may be explained
by the rotenone-induced increase in NAD(P)H level, resulting
in the increased action of enzymes that use NADPH to
regenerate GSH. An efficient regeneration of GSH may also
explain the inability of chronic rotenone to increase the
intracellular level of superoxide-derived ROS, because it allows
adequate detoxification of H2O2 by GPX. In agreement with
this explanation, chronic rotenone caused a significant but small
increase in the fraction of oxidized roGFP1 in both mitochon-
drial matrix and cytosolic compartment.
4.4. Lipid peroxidation is not detectably altered in inherited
complex I deficiency
When the production of oxidants exceeds the antioxidant
capacity of the cell, this may cause damage to lipids, proteins
and DNA. Importantly, the extent of damage to a particular
target depends, among others, on the type of oxidant involved,
the location of the target versus the oxidant, the oxidant to target
ratio and the occurrence of repair reactions. It has been
demonstrated that inadequate detoxification of H2O2 may result
in the formation of highly reactive hydroxyl radicals through the
classic Fe2+-catalyzed Fenton reaction. As far as human
complex I deficiency is concerned, experimental evidence
suggests that this condition may indeed lead to an increased
production of this radical and consequent increase in the extent
of lipid peroxidation [20]. In accordance with these results, we
demonstrated that chronic treatment with rotenone caused a 2-
fold increase in the extent of lipid peroxidation [40]. Contra-
dictory to these results, however, we now show that the extent
of lipid peroxidation is not detectably altered in patient
fibroblasts. Together with our conclusion that the GSSG/GSH
couple is the most important determinant of the cellular redox
environment and our finding that the redox state of this couple is
not detectably altered in patient fibroblasts, this finding is
compatible with previous conclusions that the presence of
sufficient amounts of GSH can prevent the occurrence of
oxidant-induced damage [59].
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